Introduction
Rates of overweight and obesity rapidly increased throughout the latter part of the 20th century, and now rank as one of the major causes of morbidity and mortality in industrialised nations.
The exact reasons for this rapid increase in obesity rates are not fully understood. There seems little doubt, however, that the major basis for any increase in the rate of obesity within a population is grounded in the basic rules of energy homeostasis and metabolism. Therefore, both increased caloric intake and the rise of the modern sedentary lifestyle, with subsequent decreased energy output, are strongly implicated as primary causes of this epidemic. These factors may be particularly likely to induce weight gain in certain genetically predisposed individuals.
Unfortunately, the increased prevalence of overweight has not been restricted to the adult population. In the US, rates of childhood overweight and obesity have increased substantially in the past 20 years. Hispanic and African Americans have been worst affected, with increases in overweight of 120% over a 12 year period, compared with a 50% increase in Caucasian children. 1 This rapid increase in childhood overweight and obesity has been accompanied by concomitant increases in childhood hypertension, 2 dyslipidaemia, 3 and type 2 diabetes 4 -diseases that, previously, were almost exclusively diseases of adulthood. The burden of overweight and obesity on premature mortality is predominantly due to the association with an increased risk of clinical cardiovascular disease, which in turn is predominantly due to the slowly progressing and prevalent disease of atherosclerosis. As we will discuss, changes in the vasculature consistent with early atherosclerosis are present and measurable in children, and can be influenced by cardiovascular risk factors including obesity. Notably, these early changes provide a potentially powerful mechanism whereby childhood obesity can impact upon adult cardiovascular disease.
Early atherosclerosis
Atherosclerosis is a multifaceted disease process involving chronic low-level inflammation, contributing to altered functional capabilities of the arterial wall, subsequent lipiddeposition and formation of the typical arterial plaque. The clinical events that are frequently the first signs of cardiovascular disease are in fact some of the final manifestations of an underlying disease process that has been progressing silently for decades. Indeed, changes to the arterial wall consistent with the earliest stages of atherosclerosis are present in utero, 5 and in post-mortem studies, arterial fatty streaks have been shown to be common, especially in the abdominal aorta, in children during the first decade of life. 6, 7 There are a variety of methods for examining the health of the vascular system. These allow for the assessment of cardiovascular health in otherwise asymptomatic subjects, and can be divided into methods for analysing vascular structure and those for analysing vascular function. Both the earliest structural and functional changes of the vasculature consistent with early atherosclerosis are present in children with cardiovascular risk factors, including familial hypercholesterolaemia 8, 9 and diabetes, 10, 11 in addition to two intrauterine factors -maternal hypercholesterolaemia 7 and impaired fetal growth.
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Vascular structure
A key indicator of atherosclerosis progression is the thickness of conduit artery walls, which is due to both lipid deposits and smooth muscle cell proliferation.
14 High-resolution ultrasound has been used for many years to assess carotid artery intima-media thickness (IMT) in adults. 15 Carotid IMT is associated with coronary atherosclerosis and future risk of stroke and myocardial infarction, 16 and provides a noninvasively obtainable measure of the total atherosclerotic burden. Similarly, early progression of aortic atherosclerosis can now be studied in vivo using an ultrasound-based measurement of the IMT of the abdominal aorta in children, which is a feasible, accurate and sensitive marker of atherosclerosis risk. 9 
Arterial stiffness
In addition to changes in arterial wall thickness, alterations to the elastic properties of the vasculature are also important indicators of vascular disease progression. Increased arterial stiffness is associated with cardiovascular risk factors, 17 and clinical cardiovascular events. 18 These alterations in arterial stiffness are measurable as changes to the arterial pulse waveform that can be assessed noninvasively. The pulse waveform is altered by the structure of the arterial vasculature from the aorta through to peripheral resistance vessels. Changes in arterial stiffness are also influenced by both endogenous and exogenous vasoactive substances. 19 Thus, changes in arterial stiffness may reflect both the structural and function health of the arterial vasculature.
Vascular endothelial function
Vascular endothelial dysfunction has been implicated as one of the key determinants of early atherogenesis. Indeed, because of its physical location at the lumenal interface of the vascular wall, and therefore on the 'frontline' of the plaque formation cascade, and its key paracrine actions, the vascular endothelium is considered to be essential to the maintenance of arterial health and the prevention of atherothrombotic cardiovascular disease. The term endothelial dysfunction is commonly used to describe the functional status of the endothelium switching from a healthy atheroprotective monolayer, to a passive single layer of cells or even to one exerting a proatherosclerotic influence. These actions of the endothelium on the promotion of, or protection from, atherosclerosis are due to the balance of substances produced and/or released by endothelial cells. Foremost of these is nitric oxide. Nitric oxide has a variety of potentially atheroprotective actions including acting as a potent vasodilator, inhibiting adhesion of monocytes to the endothelium, decreasing platelet aggregation (and consequent thrombosis) and impairing smooth muscle cell proliferation. 20 The response of the vasculature to endothelium-dependent dilators, such as acetylcholine, and also to increased shear stress are commonly used 'tests' to assess endothelial function.
Other substances produced and/or released from the endothelium include endothelin, which acts as a potent vasoconstrictor, vascular endothelial growth factor and monocyte chemoattractant protein-1, both of which affect angiogenesis, and cellular adhesion molecules (CAMs), which are involved in complex monocyte-endothelial cell interactions.
Considering the key role that the vascular endothelium plays in atherogenesis, it is not surprising that major cardiovascular risk factors such as hypercholesterolaemia, 8 type 2 diabetes, 21 hypertension, 22 ageing, male gender and smoking, 23 are all accompanied by vascular endothelial dysfunction. Endothelial function is commonly assessed in either the coronary arteries or peripheral vasculature, by examining endothelial-dependent vasodilatation in response to acetylcholine or hyperemia-induced increases in shear wall stress. 24 Noninvasive methods such as brachial arterial flow-mediated dilatation (FMD) are frequently used to assess the impact of cardiovascular risk factors and interventions, and can be studied in asymptomatic healthy subjects. Furthermore, both invasive techniques interrogating the coronary arteries and noninvasive FMD appear to be associated with the risk of future cardiovascular events.
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Obesity and atherosclerosis
The risk of death from cardiovascular disease associated with adult obesity appears to be of a similar magnitude to that associated with other major cardiac risk factors such as smoking and hypercholesterolaemia. 27 This risk is not limited to obesity in adulthood, but additionally obese
Childhood obesity and atherosclerosis MR Skilton and DS Celermajer children and adolescents are also at an increased risk of developing cardiovascular disease in adulthood. 28 While this is partly due to the tracking of obesity from childhood through adulthood, [29] [30] [31] [32] there is also an association between early obesity and cardiovascular events in adulthood independent of adult obesity. 33 Indeed, being overweight in adolescence has been demonstrated to be a stronger predictor of adult all-cause mortality, and cardiovascular disease morbidity and mortality than being overweight in adulthood. 33 This suggests that the pathophysiological changes that link obesity with cardiovascular disease are likely to be present in obese children, and furthermore, may already be influencing the genesis and progression of early atherosclerosis.
Overweight and obesity in childhood are associated with concomitant increases in cardiovascular risk factors. Lipid profile is altered by overweight in childhood, and is characterised by a decrease in high-density lipoprotein (HDL) cholesterol and a rise in low-density lipoprotein (LDL) cholesterol.
3,34-37 Blood pressure (BP), insulin resistance and glucose metabolism are also influenced by childhood overweight and obesity. 2, 4, [34] [35] [36] [37] There is evidence that the prevalence of sleep apnea, an emerging cardiovascular risk factor, is increased in obese children, as it is in obese adults. 38 C-reactive protein, an inflammatory marker, is correlated with body mass index (BMI) in children and adolescents. 39 Indeed, in this age-group BMI was a better predictor of C-reactive protein than any other cardiovascular risk factor. Additionally, there is increasing evidence that obesity is associated with changes in endothelial health in childhood and adolescence. As in adults, serum markers of endothelial cell injury and activation may provide useful information regarding endothelial health in childhood obesity. 40 Soluble
CAMs (including ICAM-1, VCAM-1 and E-selectin) are increased in obese children. [41] [42] [43] While their pathophysiological role has not yet been fully elucidated, 44 soluble adhesion molecules are commonly used as a marker of endothelial cell activation. Furthermore, obese children have higher levels of markers of platelet activation (soluble Pselectin and CD40 ligand) than healthy weight children. 41 Serum thrombomodulin, a marker of endothelial cell damage, is increased in obese adolescents. 45 Both hypertensive and normotensive obese adolescents display strikingly increased concentrations of the potent vasoconstrictor endothelin-1. 46 In addition to serum markers of vascular health, overweight and obesity are also associated with a variety of abnormal physiological measures of cardiovascular health.
In adolescents (age 14.9 years), the adipocytokine leptin is negatively correlated with arterial distensibility. 47 Furthermore, gender-specific analyses from this study demonstrate that in adolescent males, markers of anthropometry (BMI, fat mass and skinfolds -but not waist-hip-ratio) and serum insulin are related to brachial artery distensibility. These correlations were not apparent in adolescent females, with only leptin being correlated with arterial distensibility (P ¼ 0.08). Leptin was not correlated with brachial artery endothelial function, and details of the regression analyses between markers of adiposity, metabolic factors and FMD were not published.
Results from Tounian et al. 34 extend the association between obesity and arterial distensibility to children (age 12.6 years). In this study of severely obese children, carotid artery distensibility was significantly lower than in the control group. In addition to arterial distensibility being considerably decreased in obese children, arterial compliance was reduced, as was brachial artery FMD. The impairment of arterial endothelial function in obese children has since been corroborated by at least four other studies. 35, [48] [49] [50] Furthermore, these studies have extended the observations regarding obesity-related endothelial dysfunction to both children with less severe obesity, 35 obese children as young as 9 years of age, 48 and children with different ethnic backgrounds. 35, 49 Corresponding with these marked changes in arterial function and elasticity, childhood obesity is also accompanied by increases in arterial wall thickness. 35, 49, 50 These changes in arterial structure may contribute to the association between childhood overweight and adult cardiovascular disease, independent of adult overweight. In summary, obesity in childhood is associated with an increased incidence of traditional cardiovascular risk factors. Additionally, the impairment of vascular function is significant in obese children, as is arterial wall thickening. Owing to its dynamic nature, testing of vascular function presents a means to evaluate the effectiveness of obesity treatment in children, with regards to cardiovascular health. Changes in both traditional cardiovascular risk factors and vascular function may portent the long-term cardiovascular benefits of treating childhood overweight and obesity.
Diet and exercise treatment
Reduction of excess adiposity is notoriously difficult to achieve and maintain. The primary medical treatment of obesity in both adults and children involves lifestyle changes consisting of altering dietary intake (mainly via implementation of a low fat diet) and/or increasing physical activity.
There are now several studies that have examined the association between weight loss treatment and preclinical atherosclerosis in adults, which provide insights that may be pertinent to the treatment of obesity in children. A modest weight loss (of approximately 5%) is associated with improvement of nearly all major cardiac risk factors, [51] [52] [53] [54] and when maintained, a corresponding reduction in cardiovascular disease events. 55, 56 However, dietary weight loss has not been repeatedly associated with improved endothelial function, and thus may reflect the specific nutritional characteristics of the dietary regime.
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Childhood obesity and atherosclerosis MR Skilton and DS Celermajer
As little as 30 min/day of moderate-intensity physical activity is required to reduce the incidence of coronary heart disease (CHD). 59 Intervention studies indicate that this is at least partly mediated via improvements in cardiovascular risk factor profile including reduced systolic and diastolic BP, 60 In obese children, combined dietary and exercise treatment improves traditional cardiovascular risk factors. LDL cholesterol and triglycerides are decreased, and HDL cholesterol is increased, both systolic and diastolic BP are decreased, and there are also improvements in insulin resistance. 37, 68, 69 These improvements in cardiovascular risk profile are attenuated or absent when dietary treatment is used in the absence of concurrent exercise therapy. 70 Beyond traditional risk factors, there is now a growing body of evidence concerning the effects on cardiovascular health of both exercise training and dietary treatment of childhood obesity.
Woo et al. 71 randomised 82 obese children (age 9.971.0 years) to receive either exercise in conjunction with dietary advice, or dietary advice alone. The dietary programme consisted of a hypocaloric diet (900-1200 kcal/day), monitored every 2 weeks by a visit to a study dietician. The exercise programme consisted of two 75-min sessions per week, consisting of a combination of resistance training, aerobic exercise and agility training. After six weeks of treatment, neither group experienced alterations to BMI, or duel-energy X-ray absorptiometry (DEXA) assessed body fat percentage, however, waist-hip-ratio was significantly reduced in both groups. Furthermore, both diet alone and in combination with exercise treatment improved arterial endothelial function. However, these improvements in endothelial function were significantly greater in the combination exercise and diet group than in the diet alone group. Regression analyses indicated that these improvements in endothelial function were not associated with the changes in body shape, but instead were associated with exercise training and changes in serum LDL. After this short-term treatment, the subjects in the dietary group continued to follow those recommendations for the remainder of 1 year. From the 41 subjects who had previously been assigned to diet plus exercise, 22 continued with the exercise programme for one visit per week, while the other 19 ceased the exercise programme; however, continued to follow the dietary recommendations. Furthermore, visits to the dietitian were decreased to one visit every 2 months. After 1 year of treatment, BMI and waist-hip-ratio were unchanged in all groups when compared to baseline data. Fat percentage had decreased significantly in the group that continued exercise training for the entire year, and all groups displayed improved serum lipid profiles. Endothelial function continued to improve in the long-term exercise group, to levels near those of the healthy weight control subjects. The increases in FMD that were evident at 6 weeks in the diet alone group had returned to baseline levels after 1 year. In those subjects who ceased exercise training, endothelial function had decreased from the improvements seen at 6 weeks (at the cessation of the exercise programme), however, the vascular function was still significantly better than before treatment. In addition to the vascular function results, at 1 year all treatment groups had modestly reduced carotid IMT, although this was only statistically significant for the diet alone, and the continued exercise groups.
Thus, in obese children a combination of exercise and dietary therapy appears to successfully restore endothelial function to normal or near normal levels. While dietary therapy without exercise is successful at improving vascular function in the short-term, those improvements were not sustained in the long-term. This is consistent with findings from adults, where hypocaloric diets also improve endothelial function in the short-term. However, there is currently no evidence in adults as to whether these improvements are maintained over longer periods. On the other hand, dietary therapy in this study was not associated with weight loss, which is associated with improvements in FMD in adults. However, Ribeiro et al. 72 recently conducted a similar study in which the treatment resulted in significant weight loss. As in the study by Woo et al., 71 obese children were randomised to either diet alone or diet plus exercise training (consisting of three 60-min sessions per week for 4 months). Therapy significantly reduced body weight in both groups, although more markedly in the diet plus exercise group (reductions in body weight of approximately 11 & 8%). The BP response to exercise and mental stress was reduced to near-normal levels in both the diet alone, and the diet plus exercise groups. In contrast, the vasodilatation of the forearm microcirculation (a measure of vascular function) was restored to normal values in the group with exercise training in addition to dietary weight loss, but remained unchanged in the dietary therapy alone group. Thus, it appears that weight loss in children as a result of a hypocaloric diet is associated with some improvements in cardiovascular health after 4 months. While dietary therapy provides short-term improvements in vascular function, these benefits do not persist in the long-term, even when accompanied by clinically significant weight loss.
While dietary therapy alone appears to be of limited longterm benefit, neither of the above studies addressed the effectiveness of exercise alone for improving endothelial function, in the absence of dietary therapy. Watts et al. 48, 73 have published two studies using exercise training intervention alone in both obese children and adolescents. Both studies used a crossover design, with subjects receiving both 8-weeks of training and 8-weeks of nontraining, in a randomised order. In adolescents (age 14.371.5 years), the Childhood obesity and atherosclerosis MR Skilton and DS Celermajer exercise programme consisted of three 1-h sessions of circuit training per week. The circuit training consisted of both cycle ergometer and resistance training. In children (age 8.971.6 years) the exercise programme also consisted of three 1-h sessions per week; however, the physical activity involved games and recreational activities that require continuous movement, including jogging and soccer. Changes in anthropometry and body composition were minimal. There were no observed changes in BMI, weight, or skinfold thickness in either adolescents or children. DEXA scan analyses of body composition was only available in the adolescent group, and demonstrated a decrease in abdomen and trunk body fat after training. Yet despite these modest physical changes after exercise training, there were significant improvements in endothelial function in both obese children and adolescents. Indeed, in the obese adolescent subjects, the FMD was strikingly restored to the same level as the healthy weight control subjects (from 5.3 to 8.8% dilatation after 8-weeks exercise training in obese adolescents, vs 8.8% in control subjects). While also statistically significant, the improvements in vascular function in the obese children after 8-weeks of exercise training were more modest (from 6.0 to 7.4% after training), and the FMD was still relatively low when compared with the control subjects (12.3%). These findings are supported by a recent study of overweight children (aged 10.9 years) randomised to either exercise training or no treatment. 74 Exercise training consisted of stationary cycling for four sessions per week over 8 weeks. The duration of the sessions was increased from 30 min per session at the start of the intervention, to 50 min per session by the end of the intervention period. As with the above studies, FMD was increased in the exercise group, despite no change in BMI or DEXA-assessed body fat. Interestingly, there was also a trend towards a reduction in daily caloric intake among the children receiving exercise training. These studies demonstrate that vascular abnormalities consistent with early atherosclerosis, including endothelial dysfunction, are present in overweight and obese children. However, a combination of long-term dietary and exercise treatment may successfully restore vascular function to near normal levels. Optimal diet and exercise strategies, however, are yet to be defined.
Pharmacological treatment
While the use of antiobesity agents in adults has recently garnered increased attention, there have thus far been limited studies in adolescents and children. Accordingly, there is little information available regarding the cardiovascular influences of these treatments. However, it appears that sibutramine has the same cardiovascular side effects in adolescents, specifically increased heart rate and BP, as are seen in adults. 75 
Mechanisms linking obesity and atherosclerosis
The underlying mechanisms that link obesity with atherosclerosis are not fully understood. A large part of this association can be attributed to the association between obesity and other cardiovascular risk factors, including systemic hypertension, dyslipidaemia, obstructive sleep apnea, insulin resistance and type 2 diabetes. [76] [77] [78] [79] Dyslipidaemia, or more specifically the elevated LDL cholesterol form, is a direct contributor to the most distinct physical feature of atherosclerosis -the fatty plaque. In contrast, the protective influence of HDL cholesterol is mediated primarily via reverse cholesterol transport (or cholesterol efflux), and also via anti-inflammatory pathways. 80 Insulin resistance causes increases in circulating free fatty acids, possibly influences clotting and fibrinolysis, and arterial stiffness. 81, 82 The association between obstructive sleep apnea and atherosclerosis appears to be primarily mediated via coexisting factors including central obesity, insulin resistance and dyslipidaemia. 83 However, obstructive sleep apnea directly influences BP and lipid loading of macrophages. 83, 84 The mechanisms that link hypertension with atherosclerosis are not very well understood, although the physical stress on the vessel wall appears to be the primary factor involved.
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Obesity is also associated with increased levels of inflammation and oxidative stress, which are recognised as important factors influencing atherosclerosis. 86, 87 Additionally, these cardiovascular risk factors are all associated with vascular endothelial dysfunction. 88 Indeed, studies in children and adults examining the association between obesity and endothelial dysfunction have identified insulin resistance, 34 Much recent research has focused on the role of adipocytokines and other obesity-related peptides as important molecules in the pathophysiological link between increased adiposity and cardiovascular disease. The principal peptides cited include the adipocytokines resistin, leptin and adiponectin, and the growth hormone secretagogue ghrelin. These peptides influence a host of processes involved in atherosclerosis. Resistin levels are associated with circulating levels of inflammatory markers including C-reactive protein, 92 whereas ghrelin appears to have anti-inflammatory effects by inhibiting the production of interleukin-8 and monocyte chemoattractant chemokine-1. 93 Leptin has prothrombotic effects, 94, 95 and also increases oxidative stress. 96 Adiponectin has wide-ranging antiatherosclerotic effects including upregulating endothelial nitric oxide synthase, decreasing superoxide production by endothelial cells and inhibiting lipid accumulation in human monocyte-derived macrophages. [97] [98] [99] There is evidence that all of these obesity-related peptides alter vascular tone or function. [100] [101] [102] [103] Additionally, resistin, adiponectin and ghrelin all influence the expression of CAMs on vascular endothelial cells.
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Finally, the physical stresses that accompany increases in body mass may contribute to cardiovascular disease. The increased volume load on both the ventricles, and small and large blood vessels, potentially tie obesity with pathological changes to the vasculature.
These pathophysiological factors create a schematic linking obesity to cardiovascular disease (see Figure 1) . However, despite the lack of a single easily identifiable pathway, the abundance of interacting factors that link overweight with cardiovascular disease combine to paint a uniform portraitthat of an important (although potentially reversible) link between childhood obesity and cardiovascular disease.
As above, these factors may be differentially affected by the various treatments for obesity -dietary, exercise, pharmacological or surgical -as well as the amount of weight loss and changes in the quantity and distribution of body fat. As these relationships become clear, a priority should be placed upon treatments for childhood obesity that not only result in relative weight loss, but also possess independent and beneficial effects on measures of cardiovascular health.
Conclusions
In adults, obesity is associated with an increased risk of clinical cardiovascular events. In obese children, there are significant and measurable changes in vascular structure and function, both of which are indicative of the early stages of cardiovascular disease.
There is currently little evidence regarding the effects on the vasculature in children of pharmacological treatments for obesity. Dietary treatment alone provides transient shortterm improvements in endothelial function, although these do not persist after 1 year of treatment. These changes in vascular function may be altered by the nutritional constitution of the diet, independent of weight loss. On the other hand, an exercise regime, consisting of as little as three 1-h sessions per week, can improve endothelial function in obese children and adolescents. In combination with long-term dietary treatment, regular exercise training restores and maintains endothelial function at near-normal levels, in overweight and obese children, even without impressive weight loss. These changes are consistent with a decreased risk of atherosclerotic progression and reduced risk of cardiovascular disease, and thus strongly support the use of regular exercise in combination with dietary therapy as the cornerstones for treatment of overweight and obesity in childhood.
